Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic human anti-IL-1R1 monoclonal antibody

Therapeutic human anti-IL-1R1 monoclonal antibody

US Patent 9534053 · Granted Jan 3, 2017

Estimated economic value: $273,374,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tumor necrosis factor-like ligand 1A specific antibodies and compositions and us2025
Anti-interleukin-23 P19 antibodies and methods of use thereof2025
Human IL-4R binding antibody, antigen binding fragment thereof, and medical use 2024
Anti-CD27 antibodies and uses thereof2024
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) 2023
Anti-PD-L1 antibodies2023
Dental strips for the delivery of specifically targeted antimicrobial peptides2023
Dental varnishes that release specifically targeted antimicrobial peptides and/o2023
Anti-CD40 antibody, antigen binding fragment thereof and medical use thereof2022
Tumor necrosis factor-like ligand 1A specific antibodies and compositions and us2022
Anti-CLauDiN 18 antibodies and methods of use thereof2022
Anti-GITR antibodies for cancer diagnostics2022